September 13, 2022
FDA approves durvalumab to treat biliary tract cancer in combination with chemotherapy.
New research adds further evidence that early in life antibiotic exposure can have lifelong impact.
September 06, 2022
This new treatment option copackages 3 drugs for optimal treatment.
August 30, 2022
New research examines how often immune-mediated inflammatory skin diseases occur in patients with inflammatory bowel disease.
August 26, 2022
Although further studies are needed to confirm the long-term effects, recent studies have shown the infliximab biosimilar to be a safe, effective, and cost reducing treatment for inflammatory bowel diseases.
August 10, 2022
The American Gastroenterological Association has released updated guidelines for treating irritable bowel syndrome with constipation (IBS-C).
August 08, 2022
Treatments, including some biosimilars, may soon be offering relief to patients.
June 24, 2022
Pharmacists who encounter patients with severe gastrointestinal complains may want to stay abreast of ongoing issues with the meal delivery service.
June 15, 2022
New options are being developed for conditions including psoriatic arthritis, ulcerative colitis, and asthma.
June 01, 2022
High-dose haloperidol and aprepitant were both associated with emergency department discharge.
